{"id":10131,"date":"2025-01-24T13:41:54","date_gmt":"2025-01-24T08:11:54","guid":{"rendered":"https:\/\/indianpharmanetwork.co.in\/medicines\/?post_type=product&#038;p=10131"},"modified":"2025-06-19T19:53:49","modified_gmt":"2025-06-19T14:23:49","slug":"vyloy-zolbetuximab-clzb-for-injection","status":"publish","type":"product","link":"https:\/\/indianpharmanetwork.co.in\/medicines\/product\/vyloy-zolbetuximab-clzb-for-injection\/","title":{"rendered":"VYLOY (zolbetuximab-clzb) for injection"},"content":{"rendered":"<p>Zolbetuximab, sold under the brand name Vyloy, is a monoclonal antibody used for the treatment of gastric cancer. It is a claudin 18.2-directed cytolytic antibody against isoform 2 of Claudin-18. Zolbetuximab was developed by Ganymed Pharmaceuticals. Astellas Pharma acquired the rights to zolbetuximab in December 2016, when it acquired Ganymed Pharmaceuticals.<\/p>\n<p>Zolbetuximab was approved for medical use in Japan in March 2024, the European Union in September 2024, and the United States in October 2024. The US Food and Drug Administration (FDA) considers it to be a first-in-class medication.<\/p>\n<h4>VYLOY (zolbetuximab-clzb) for injection, for intravenous use Initial U.S. Approval: 2024<\/h4>\n<h4>Is VYLOY available in India?<\/h4>\n<p><strong>VYLOY (zolbetuximab-clzb) for injection<\/strong> is a (prescription drug, prescription medication, or prescription medicine) pharmaceutical drug that legally requires a medical prescription to be dispensed.<\/p>\n<p><strong>If VYLOY (zolbetuximab-clzb) for injection are not yet approved or available in your area, you may request its price in India under a specific brand name through IPN.<\/strong> For assistance and guidance, you can contact us by providing complete details. Our pharmaceutical expert will help you find a suitable and practical solution to your query.<strong> Like 1. How to get access in in India. 2. Medicine Price. 3. Finding Genuine and reliable sources from the USA, Canada, Europe, and Australia. 4. Ensuring 100% transparency.\u00a0<\/strong><\/p>\n<p>VYLOY (zolbetuximab-clzb) for injection can be made available to patients, doctors, and hospitals in Mumbai, Delhi, Kolkata, Bhubaneswar, Bangalore, Hyderabad, Chennai, Ahmedbad, Pune, Surat, Visakhapatnam, Jaipur, Lucknow, Nagpur, Indore, Patna, Agartala, Guwahati, Imphal, Kohima, Namchi, Noida, Ghaziabad, Ludhiana, Agra, Varanasi, Srinagar, Amritsar, Jodhpur, Chandigarh, Gurgaon, Gorakhpur, Dehradun, Jammu, Hyderabad, Thiruvananthapuram, Kochi, Coimbatore, Puducherry, Mysuru, Salem, Vellore, Tiruppur, Guntur, Goa, Kolhapur, Mumbai, Nashik, and various other regions in India. The order will be confirmed only after the receipt of a valid prescription from the doctor and an import permit.<\/p>\n<p><strong>To receive comprehensive support, please call us at <a href=\"tel:9811747774\">9811747774<\/a>, <a href=\"tel:9891296838\">9891296838<\/a> or WhatsApp at <a href=\"https:\/\/wa.me\/+919811747774\" target=\"_blank\" rel=\"noopener\">9811747774<\/a>, <a href=\"https:\/\/wa.me\/+919891296838\" target=\"_blank\" rel=\"noopener\"> 9891296838 <\/a>or email us at <a href=\"mailto:info@indianpharmanetwork.co.in\" target=\"_blank\" rel=\"noopener\">info@indianpharmanetwork.co.in\u00a0<\/a> for VYLOY (zolbetuximab-clzb) for injection price in India.<\/strong><\/p>\n<h4>NEWS \/ UPDATES<\/h4>\n<ol>\n<li><a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761365s000lbl.pdf\" target=\"_blank\" rel=\"noopener\">HIGHLIGHTS OF PRESCRIBING INFORMATION<\/a>. Accessdata.fda.gov, Accessed 21 November 2024.<\/li>\n<li><a href=\"https:\/\/www.ema.europa.eu\/en\/medicines\/human\/EPAR\/vyloy\" target=\"_blank\" rel=\"noopener\">Vyloy | European Medicines Agency (EMA)<\/a>. European Medicines Agency, 23 September 2024.<\/li>\n<li><a href=\"https:\/\/www.fda.gov\/drugs\/resources-information-approved-drugs\/fda-approves-zolbetuximab-clzb-chemotherapy-gastric-or-gastroesophageal-junction-adenocarcinoma\" target=\"_blank\" rel=\"noopener\">FDA approves zolbetuximab-clzb with chemotherapy for gastric or gastroesophageal junction adenocarcinoma<\/a>. FDA, 18 October 2024.<\/li>\n<\/ol>\n<p><em><strong>Note:<\/strong><\/em><br \/>\n<em>We are the facilitator, group of highly qualified healthcare professionals, provide solutions on how to get access of anti cancer medicines not available in India. On the basis of permission in Form 12B (Import permit) from From Ministry of Health, Government of India, IPN, New Delhi procure drugs on behalf of patient. <a href=\"https:\/\/indianpharmanetwork.co.in\/about-ipn.php\">Indian Pharma Network (IPN) serves as a legitimate consultant and facilitator situated in New Delhi, India<\/a>. With over two decades of industry experience, IPN offers extensive coverage across India.<\/em><\/p>\n","protected":false},"excerpt":{"rendered":"<h2>Brand Name: VYLOY Generic Name: (zolbetuximab-clzb). It is used to treat stomach and esophagus cancer.<\/h2>\n<p>VYLOY (zolbetuximab-clzb) is a drug used to treat certain types of stomach and esophagus cancer in adults. It&#8217;s given in combination with chemotherapy.<\/p>\n<table border=\"1\" width=\"95%\">\n<tbody>\n<tr>\n<td><strong>Brand Name:<\/strong><\/td>\n<td>VYLOY<\/td>\n<\/tr>\n<tr>\n<td><strong>Generic Name:<\/strong><\/td>\n<td>zolbetuximab-clzb<\/td>\n<\/tr>\n<tr>\n<td><strong>Strength:<\/strong><\/td>\n<td>\u2022 For injection: 100 mg lyophilized powder in a single-dose vial<\/td>\n<\/tr>\n<tr>\n<td><strong>Manufacturer:<\/strong><\/td>\n<td>Astellas Pharma<\/td>\n<\/tr>\n<tr>\n<td><strong>Approved By:<\/strong><\/td>\n<td>EMA, USFDA<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Source Details:\u00a0<a href=\"https:\/\/www.accessdata.fda.gov\/drugsatfda_docs\/label\/2024\/761365s000lbl.pdf\" target=\"_blank\" rel=\"noopener\"><strong>Patient Information<\/strong><\/a><\/p>\n<p><em><strong data-sider-select-id=\"0264f273-b082-496a-b3a6-36bbf779f0ec\">IPN, New Delhi can facilitate patient to import of \u201cVYLOY (zolbetuximab-clzb)\u201d<\/strong>\u00a0in small quantities for personal use. For this applicant is required to make an application in Form 12A, along with the prescription of the Registered Medical Practitioner (RMP). If you have any question, please\u00a0<a href=\"mailto:urgent@indianpharmanetwork.co.in\" target=\"_blank\" rel=\"noopener\">email IPN healthcare Support Team\u00a0<\/a>for<strong> pharma product<\/strong>\u00a0cost in India. on <strong>Mr. Tarun:- +91 9891 296 838 \/ Mr. Neeraj:- +91 9811 747 774.<\/strong><\/em><\/p>\n","protected":false},"featured_media":10138,"template":"","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":""},"product_brand":[],"product_cat":[183,185,182],"product_tag":[],"class_list":{"0":"post-10131","1":"product","2":"type-product","3":"status-publish","4":"has-post-thumbnail","6":"product_cat-stomach","7":"product_cat-esophageal","8":"product_cat-gastrointestinal","10":"first","11":"instock","12":"shipping-taxable","13":"product-type-simple"},"_links":{"self":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product\/10131","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product"}],"about":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/types\/product"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media\/10138"}],"wp:attachment":[{"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/media?parent=10131"}],"wp:term":[{"taxonomy":"product_brand","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_brand?post=10131"},{"taxonomy":"product_cat","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_cat?post=10131"},{"taxonomy":"product_tag","embeddable":true,"href":"https:\/\/indianpharmanetwork.co.in\/medicines\/wp-json\/wp\/v2\/product_tag?post=10131"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}